Analytical Bias in the Measurement of Serum 25-Hydroxyvitamin D Concentrations Impairs Assessment of Vitamin D Status in Clinical and Research Settings

被引:48
作者
Black, Lucinda J. [1 ]
Anderson, Denise [1 ]
Clarke, Michael W. [2 ]
Ponsonby, Anne-Louise [3 ]
Lucas, Robyn M. [1 ,4 ]
机构
[1] Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia
[2] Univ Western Australia, Metabol Australia, Ctr Metabol, Perth, WA 6009, Australia
[3] Univ Melbourne, Murdoch Childrens Res Inst, Melbourne, Vic, Australia
[4] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Res Sch Populat Hlth, Canberra, ACT, Australia
基金
澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;
关键词
MULTIPLE-SCLEROSIS; D ASSAYS; ADULTS; 25-HYDROXYCHOLECALCIFEROL; STANDARDIZATION; CHROMATOGRAPHY; METABOLITES; PREVALENCE; NUTRITION; ACCURACY;
D O I
10.1371/journal.pone.0135478
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Measured serum 25-hydroxyvitamin D concentrations vary depending on the type of assay used and the specific laboratory undertaking the analysis, impairing the accurate assessment of vitamin D status. We investigated differences in serum 25-hydroxyvitamin D concentrations measured at three laboratories (laboratories A and B using an assay based on liquid chromatography-tandem mass spectrometry and laboratory C using a DiaSorin Liaison assay), against a laboratory using an assay based on liquid chromatography-tandem mass spectrometry that is certified to the standard reference method developed by the National Institute of Standards and Technology and Ghent University (referred to as the 'certified laboratory'). Separate aliquots from the same original serum sample for a subset of 50 participants from the Ausimmune Study were analysed at the four laboratories. Bland-Altman plots were used to visually check agreement between each laboratory against the certified laboratory. Compared with the certified laboratory, serum 25-hydroxyvitamin D concentrations were on average 12.4 nmol/L higher at laboratory A (95% limits of agreement: -17.8,42.6); 12.8 nmol/L higher at laboratory B (95% limits of agreement: 0.8,24.8); and 10.6 nmol/L lower at laboratory C (95% limits of agreement: -48.4,27.1). The prevalence of vitamin D deficiency (defined here as 25-hydroxyvitamin D <50 nmol/L) was 24%, 16%, 12% and 41% at the certified laboratory, and laboratories A, B, and C, respectively. Our results demonstrate considerable differences in the measurement of 25-hydroxyvitamin D concentrations compared with a certified laboratory, even between laboratories using assays based on liquid chromatography-tandem mass spectrometry, which is often considered the gold-standard assay. To ensure accurate and reliable measurement of serum 25-hydroxyvitamin D concentrations, all laboratories should use an accuracy-based quality assurance system and, ideally, comply with international standardisation efforts.
引用
收藏
页数:14
相关论文
共 33 条
[1]  
[Anonymous], MCR METHOD COMP REGR
[2]  
[Anonymous], NAT DIET NUTR SURV H
[3]   UK Food Standards Agency Workshop Report: an investigation of the relative contributions of diet and sunlight to vitamin D status [J].
Ashwell, Margaret ;
Stone, Elaine M. ;
Stolte, Heiko ;
Cashman, Kevin D. ;
Macdonald, Helen ;
Lanham-New, Susan ;
Hiom, Sara ;
Webb, Ann ;
Fraser, David .
BRITISH JOURNAL OF NUTRITION, 2010, 104 (04) :603-611
[4]  
Australian Bureau of Statistics, 2014, AUSTR HLTH SURV BIOM
[5]  
Australian Government Department of Health, 2014, MBS REV VIT D TESTIN
[6]   Analytical measurement and clinical relevance of vitamin D3 C3-epimer [J].
Bailey, Dana ;
Veljkovic, Kika ;
Yazdanpanah, Mehrdad ;
Adeli, Khosrow .
CLINICAL BIOCHEMISTRY, 2013, 46 (03) :190-196
[7]   RAPID ASSAY FOR 25-HYDROXY-VITAMIN-D3 WITHOUT PREPARATIVE CHROMATOGRAPHY [J].
BELSEY, RE ;
DELUCA, HF ;
POTTS, JT .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1974, 38 (06) :1046-1051
[8]   Evidence of overtesting for vitamin D in Australia: an analysis of 4.5 years of Medicare Benefits Schedule (MBS) data [J].
Bilinski, Kellie ;
Boyages, Steve .
BMJ OPEN, 2013, 3 (06)
[9]   STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1986, 1 (8476) :307-310
[10]  
Carter GD, 2011, CURR DRUG TARGETS, V12, P19